Article Details
Retrieved on: 2024-11-26 17:16:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study led by Dr. Louis Aronne, highlighting tirzepatide's efficacy in preventing type 2 diabetes by inducing weight loss in prediabetic and obese patients. This peptide therapeutic activates GLP-1 and GIP receptors.
Article found on: www.news-medical.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here